Liver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective.

Background: Fibrolamellar Hepatocellular Carcinoma (FL-HCC) is a rare primary liver tumor that usually presents in younger patients without underlying liver disease.

Methods: We queried the United Network of Organ Sharing (UNOS) database between October 1988 and January 2013 to evaluate outcomes in patients with FL-HCC undergoing liver transplantation in the United States compared to patients with conventional Hepatocellular Carcinoma (HCC).

Results: Sixty-three patients were identified (57% female, mean age 30 years).